Glycopyrrolate
Product Images NDC 0404-9869

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 0404-9869). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

This is a chemical compound with the molecular formula CHBNO and a molecular weight of 338.33. Unfortunately, there is no further information available as the text appears incomplete or scrambled.*

FDA Label Image

Image1.jpg (Image1)

FDA Label Image

Image2.jpg (Image2)

WEST-WARD A HIKMA COMPANY. This product is manufactured by HIKMA FARMACEUTICA (PORTUGAL), S.A., located in Portugal and distributed by WEST-WARD PHARMACEUTICAL CORP in the USA. The revision date is November 2019.*

FDA Label Image

Label1.jpg (Label1)

This is a description of a medication called Glycopyrrolate in the form of a 0.2g/0.4mg injection. It comes in a single dose vial meant for intramuscular or intravenous administration and should not be used on newborns. The medication contains benzyl alcohol and should be kept out of reach of children. The recommended storage temperature is between 20 to 25°C (66 to 77°F) and it is produced by a company called Heaty Schein, Inc. The text includes some identification codes and refers to manufacturer-provided prescribing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.